Cargando…

Next‐generation sequencing unravels extensive genetic alteration in recurrent ovarian cancer and unique genetic changes in drug‐resistant recurrent ovarian cancer

BACKGROUND: By using a high‐throughput sequencing technique, we sought to delineate genetic alterations in recurrent ovarian cancer patients and further compare genetic changes in drug‐resistant and ‐sensitive recurrent ovarian cancer patients. We also sought to study the specificity, sensitivity, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Zhen‐Hua, Bi, Fang‐Fang, Wang, Lei, Yang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081217/ https://www.ncbi.nlm.nih.gov/pubmed/29797793 http://dx.doi.org/10.1002/mgg3.414

Ejemplares similares

Genetics of Primary Ovarian Insufficiency in the Next-Generation Sequencing Era
por: França, Monica Malheiros, et al.
Publicado: (2019)

Next-generation sequencing: unraveling genetic mechanisms that shape cancer immunotherapy efficacy
por: Halima, Ahmed, et al.
Publicado: (2022)

An integrative model for recurrence in ovarian cancer
por: Laios, Alexandros, et al.
Publicado: (2008)

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

Palbociclib in the treatment of recurrent ovarian cancer
por: Lee, Dai Wee, et al.
Publicado: (2020)

Treatment of Recurrent Epithelial Ovarian Cancer
por: Claussen, Carlota, et al.
Publicado: (2020)

Genetic alterations and their therapeutic implications in epithelial ovarian cancer
por: Lapke, Nina, et al.
Publicado: (2021)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
por: Kluska, Anna, et al.
Publicado: (2015)

Next Generation of Ovarian Cancer Detection Using Aptamers
por: Abreu, Rayane da Silva, et al.
Publicado: (2023)

Weekly platinum chemotherapy for recurrent ovarian cancer
por: Clamp, A, et al.
Publicado: (2002)

Treatment for Recurrent Ovarian Cancer—At First Relapse
por: Ushijima, Kimio
Publicado: (2010)

The Role of Secondary Surgery in Recurrent Ovarian Cancer
por: Lorusso, D., et al.
Publicado: (2012)

Introduction to managing patients with recurrent ovarian cancer
por: Gabra, Hani
Publicado: (2014)

Cardiac Tamponade Unmasking Recurrent Ovarian Cancer
por: Maryniak, Andrii, et al.
Publicado: (2021)

Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues
por: Gan, Meifu, et al.
Publicado: (2023)

The genetics of breast and ovarian cancer.
por: Ford, D., et al.
Publicado: (1995)

The genetic analysis of ovarian cancer.
por: Shelling, A. N., et al.
Publicado: (1995)

Systematic Review of Olaparib in the Treatment of Recurrent Platinum Sensitive Ovarian Cancer
por: Chen, Qian, et al.
Publicado: (2022)

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2011)

Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing
por: Ratajska, Magdalena, et al.
Publicado: (2014)

VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
por: Song, Jin, et al.
Publicado: (2023)

Ovarian cancer risk assessment in the era of next-generation sequencing
por: Bonadio, Renata Colombo, et al.
Publicado: (2020)

Recurrence Rate and Risk Factors for the Recurrence of Ovarian Endometriosis after Laparoscopic Ovarian Cystectomy
por: Wacharachawana, Sornsittipong, et al.
Publicado: (2021)

Remote Recurrence from Ovarian Cancer Mimicking Lung Cancer
por: Yamada, Sho, et al.
Publicado: (2021)

Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness
por: Huang, Zhiqing, et al.
Publicado: (2023)

Optimal chemotherapy treatment for women with recurrent ovarian cancer
por: Fung-Kee-Fung, M., et al.
Publicado: (2007)

Tertiary cytoreduction in the setting of recurrent ovarian cancer (Review)
por: DOGAN, NASUH UTKU, et al.
Publicado: (2013)

The role of asymptomatic screening in the detection of recurrent ovarian cancer
por: Richardson, M.T., et al.
Publicado: (2020)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
por: Certelli, Camilla, et al.
Publicado: (2023)

Surgery in Recurrent Ovarian Cancer: A Meta-Analysis
por: Climent, Maria Teresa, et al.
Publicado: (2023)

An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids
por: Chen, Yu-An, et al.
Publicado: (2022)

Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer
por: TANG, QINGLING, et al.
Publicado: (2023)

Oophoropexy for Recurrent Ovarian Torsion
por: Hartley, Jennifer, et al.
Publicado: (2018)

Recurrent BRCA1 Mutation, but no BRCA2 Mutation, in Vietnamese Patients with Ovarian Carcinoma Detected with Next Generation Sequencing
por: Vu, Hoang Anh, et al.
Publicado: (2020)

Next steps in the early detection of ovarian cancer
por: Bast, Robert C., et al.
Publicado: (2021)

Genetic and molecular changes in ovarian cancer
por: Hollis, Robert L, et al.
Publicado: (2016)

Surgery in platinum-resistant recurrent epithelial ovarian carcinoma
por: Zhao, Ling-Qin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m2avnrvqd3luuavqos8l21vv5o